Literature DB >> 12079402

Dopamine has a critical role in photoreceptor degeneration in the rd mouse.

Judith Mosinger Ogilvie1, Judith D Speck.   

Abstract

Photoreceptors receive paracrine input from dopaminergic interplexiform cells. Rod photoreceptors in the rd mouse degenerate rapidly due to a specific gene defect. We investigated the effects of dopamine on rd mouse photoreceptors in retinal organ culture. Retinas were harvested from rd or wild-type mice at postnatal day 2 and grown in organ culture for 27 days. When antagonists for either D(1)- or D(2)-family dopamine receptors were added to the media, photoreceptor degeneration was blocked. Furthermore, when dopamine was depleted by the addition of 6-hydroxydopamine and pargyline, photoreceptor survival appeared comparable to wild-type retinal cultures. The addition of a dopamine agonist induced photoreceptor degeneration in dopamine-depleted rd organ cultures. In all cases, photoreceptors maintained robust staining of opsin. These results demonstrate that dopamine antagonists or dopamine depletion blocks photoreceptor degeneration and that dopamine is necessary for photoreceptor degeneration in the rd mouse retinal organ culture model, indicating that dopamine antagonists may represent a therapeutic strategy in retinal degenerative disease. 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079402     DOI: 10.1006/nbdi.2002.0489

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  Prejunctional inhibitory effects of isoprostanes on dopaminergic neurotransmission in bovine retinae, in vitro.

Authors:  Hong Liu; Min Zhao; Catherine A Opere
Journal:  Neurochem Res       Date:  2007-08-03       Impact factor: 3.996

2.  Circadian organization of the mammalian retina.

Authors:  Guo-Xiang Ruan; Dao-Qi Zhang; Tongrong Zhou; Shin Yamazaki; Douglas G McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 3.  Circadian organization of the mammalian retina: from gene regulation to physiology and diseases.

Authors:  Douglas G McMahon; P Michael Iuvone; Gianluca Tosini
Journal:  Prog Retin Eye Res       Date:  2013-12-12       Impact factor: 21.198

4.  Inhibition of dopamine signaling suppresses cGMP accumulation in rd1 retinal organ cultures.

Authors:  Ju Zhang; Angela M Richmond; Judith M Ogilvie
Journal:  Neuroreport       Date:  2014-05-28       Impact factor: 1.837

5.  Assessing the functional coherence of gene sets with metrics based on the Gene Ontology graph.

Authors:  Adam J Richards; Brian Muller; Matthew Shotwell; L Ashley Cowart; Bäerbel Rohrer; Xinghua Lu
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

Review 6.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

7.  Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors.

Authors:  Qing Chang; Evgeny Berdyshev; Dingcai Cao; Joseph D Bogaard; Jerry J White; Siquan Chen; Ravi Shah; Wenbo Mu; Rita Grantner; Sam Bettis; Michael A Grassi
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

8.  Divergent roles of clock genes in retinal and suprachiasmatic nucleus circadian oscillators.

Authors:  Guo-Xiang Ruan; Karen L Gamble; Michael L Risner; Laurel A Young; Douglas G McMahon
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

9.  Newly Identified Chemicals Preserve Mitochondrial Capacity and Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models.

Authors:  Craig Beeson; Yuri K Peterson; Nathan Perron; Mausumi Bandyopadhyay; Cecile Nasarre; Gyda Beeson; Richard F Comer; Christopher C Lindsey; Rick G Schnellmann; Bärbel Rohrer
Journal:  J Ocul Pharmacol Ther       Date:  2021-05-04       Impact factor: 2.850

10.  Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo.

Authors:  Judith Mosinger Ogilvie; Angela M Hakenewerth; Rachel R Gardner; Joshua G Martak; Virginia M Maggio
Journal:  Mol Vis       Date:  2009-12-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.